BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30873846)

  • 1. Expression of IL-25, IL-33, and Thymic Stromal Lymphopoietin in Nasal Polyp Gland Duct Epithelium in Patients With Chronic Rhinosinusitis.
    Nagata Y; Maruoka S; Gon Y; Mizumura K; Kishi H; Nomura Y; Hikichi M; Hashimoto S; Oshima T
    Am J Rhinol Allergy; 2019 Jul; 33(4):378-387. PubMed ID: 30873846
    [No Abstract]   [Full Text] [Related]  

  • 2. Epithelium-derived cystatin SN enhances eosinophil activation and infiltration through IL-5 in patients with chronic rhinosinusitis with nasal polyps.
    Yan B; Lou H; Wang Y; Li Y; Meng Y; Qi S; Wang M; Xiao L; Wang C; Zhang L
    J Allergy Clin Immunol; 2019 Aug; 144(2):455-469. PubMed ID: 30974106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma.
    Saitoh T; Kusunoki T; Yao T; Kawano K; Kojima Y; Miyahara K; Onoda J; Yokoi H; Ikeda K
    Int Arch Allergy Immunol; 2010; 151(1):8-16. PubMed ID: 19672092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial Cell-Derived Cytokines Contribute to the Pathophysiology of Eosinophilic Chronic Rhinosinusitis.
    Kouzaki H; Matsumoto K; Kato T; Tojima I; Shimizu S; Shimizu T
    J Interferon Cytokine Res; 2016 Mar; 36(3):169-79. PubMed ID: 26540312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of Type 2 Cytokines by Epithelial Cells of Nasal Polyps.
    Boita M; Bucca C; Riva G; Heffler E; Rolla G
    J Immunol Res; 2016; 2016():2643297. PubMed ID: 28127565
    [No Abstract]   [Full Text] [Related]  

  • 6. Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis.
    Yamada T; Miyabe Y; Ueki S; Fujieda S; Tokunaga T; Sakashita M; Kato Y; Ninomiya T; Kawasaki Y; Suzuki S; Saito H
    Front Immunol; 2019; 10():74. PubMed ID: 30778348
    [No Abstract]   [Full Text] [Related]  

  • 7. Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polyps.
    Chen D; Mao M; Bellussi LM; Passali D; Chen L
    Int Forum Allergy Rhinol; 2014 Jun; 4(6):453-62. PubMed ID: 24504744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of thymic stromal lymphopoietin, IL-33, and their receptors in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps.
    Liao B; Cao PP; Zeng M; Zhen Z; Wang H; Zhang YN; Hu CY; Ma J; Li ZY; Song J; Liu JX; Peng LY; Liu Y; Ning Q; Liu Z
    Allergy; 2015 Sep; 70(9):1169-80. PubMed ID: 26095319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical severity and epithelial endotypes in chronic rhinosinusitis.
    Lam M; Hull L; McLachlan R; Snidvongs K; Chin D; Pratt E; Kalish L; Sacks R; Earls P; Sewell W; Harvey RJ
    Int Forum Allergy Rhinol; 2013 Feb; 3(2):121-8. PubMed ID: 23038685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic inflammation of chronic rhinosinusitis with nasal polyps is related to OX40 ligand expression.
    Boita M; Garzaro M; Raimondo L; Riva G; Mazibrada J; Pecorari G; Bucca C; Bellone G; Vizio B; Heffler E; Ricciardolo FL; Rolla G
    Innate Immun; 2015 Feb; 21(2):167-74. PubMed ID: 24583911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chronic rhinosinusitis on severe asthma patients.
    Lee TJ; Fu CH; Wang CH; Huang CC; Huang CC; Chang PH; Chen YW; Wu CC; Wu CL; Kuo HP
    PLoS One; 2017; 12(2):e0171047. PubMed ID: 28199345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of IL-17 and syndecan-1 in nasal polyps and their correlation with nasal polyps.
    Gong GQ; Ren FF; Wang YJ; Wan L; Chen S; Yuan J; Yang CM; Liu BH; Kong WJ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):412-418. PubMed ID: 28585128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch-1 signaling activation sustains overexpression of interleukin 33 in the epithelium of nasal polyps.
    Chiappara G; Sciarrino S; Di Sano C; Gallina S; Speciale R; Lorusso F; Di Vincenzo S; D'Anna C; Bruno A; Gjomarkaj M; Pace E
    J Cell Physiol; 2019 Apr; 234(4):4582-4596. PubMed ID: 30259982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial activators of type 2 inflammation: Elevation of thymic stromal lymphopoietin, but not IL-25 or IL-33, in chronic rhinosinusitis with nasal polyps in Chicago, Illinois.
    Ogasawara N; Klingler AI; Tan BK; Poposki JA; Hulse KE; Stevens WW; Peters AT; Grammer LC; Welch KC; Smith SS; Conley DB; Kern RC; Schleimer RP; Kato A
    Allergy; 2018 Nov; 73(11):2251-2254. PubMed ID: 29987901
    [No Abstract]   [Full Text] [Related]  

  • 15. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4.
    Soyka MB; Wawrzyniak P; Eiwegger T; Holzmann D; Treis A; Wanke K; Kast JI; Akdis CA
    J Allergy Clin Immunol; 2012 Nov; 130(5):1087-1096.e10. PubMed ID: 22840853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc17/IL-17A Up-Regulated the Expression of MMP-9 via NF-κB Pathway in Nasal Epithelial Cells of Patients With Chronic Rhinosinusitis.
    Chen X; Chang L; Li X; Huang J; Yang L; Lai X; Huang Z; Wang Z; Wu X; Zhao J; Bellanti JA; Zheng SG; Zhang G
    Front Immunol; 2018; 9():2121. PubMed ID: 30283454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remodeling and inflammation in Chinese versus white patients with chronic rhinosinusitis.
    Zhang N; Liu S; Lin P; Li X; van Bruaene N; Zhang J; van Zele T; Bachert C
    J Allergy Clin Immunol; 2010 Feb; 125(2):507; author reply 507-8. PubMed ID: 20061013
    [No Abstract]   [Full Text] [Related]  

  • 18. Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps and airway hypersensitiveness: A pilot study.
    Chen F; Hong H; Sun Y; Hu X; Zhang J; Xu G; Zhao W; Li H; Shi J
    Ann Allergy Asthma Immunol; 2017 Oct; 119(4):310-316.e2. PubMed ID: 28870448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and role of IL-33 and its receptor ST2 in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps].
    Liu T; Lv C; Cao Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 29(15):1350-3, 1371. PubMed ID: 26685400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Effects of Intranasal Tofacitinib on Chronic Rhinosinusitis with Nasal Polyps in Mice.
    Joo YH; Cho HJ; Jeon YJ; Kim JH; Jung MH; Jeon SY; Suh YS; Park JJ; Kim SW
    Laryngoscope; 2021 May; 131(5):E1400-E1407. PubMed ID: 32990335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.